An examination of semantic performance in mild cognitive impairment progressors and nonprogressors.

by Clinical Neuropsychologist | Thursday, February 15, 2024 | Neuropsychology (general)

Neuropsychology, Vol 38(4), May 2024, 309-321; doi:10.1037/neu0000947Objective: Mild cognitive impairment (MCI) is a risk factor for developing Alzheimer’s disease (AD), and about half of older people with MCI will progress to AD within the next 5 years. The aim of...

Comparing embedded performance validity indicators within the WAIS-IV Letter-Number sequencing subtest to Reliable Digit Span among adults referred for evaluation of attention-deficit/hyperactivity disorder

by Clinical Neuropsychologist | Wednesday, February 14, 2024 | Neuropsychology (general)

Volume 38, Issue 7, October 2024, Page 1647-1666. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: John-Christopher A. Finley Violeta J. Rodriguez Brian M....

Antecedents of mind wandering states in healthy aging and mild cognitive impairment.

by Clinical Neuropsychologist | Thursday, February 8, 2024 | Neuropsychology (general)

Neuropsychology, Vol 38(5), Jul 2024, 430-442; doi:10.1037/neu0000941Objective: Mind wandering refers to periods of internally directed attention and comprises up to 30% or more of our waking thoughts. Frequent mind wandering can be detrimental to ongoing task...

Processing speed in first episode of psychosis and first-degree relatives: A candidate endophenotype of spectrum schizophrenia disorders.

by Clinical Neuropsychologist | Thursday, February 8, 2024 | Neuropsychology (general)

Neuropsychology, Vol 38(4), May 2024, 357-367; doi:10.1037/neu0000931Objective: The processing speed (PS) is highly impacted in individuals experiencing their first episode of psychosis (FEP). Conducting family studies can help to determine whether PS can serve as an...

Association between neuropsychological assessment and amyloid status in a clinical setting.

by Clinical Neuropsychologist | Thursday, February 8, 2024 | Neuropsychology (general)

Neuropsychology, Vol 38(4), May 2024, 337-346; doi:10.1037/neu0000938Objective: Large research cohorts show robust associations between neuropsychological tests and Alzheimer’s disease (AD) biomarkers, but studies in clinical settings are limited. The increasing...

Language switching and speaking a nondominant language challenge executive control: Preliminary data for novel behavioral markers of Alzheimer’s risk in Spanish–English bilinguals.

by Clinical Neuropsychologist | Thursday, February 8, 2024 | Neuropsychology (general)

Neuropsychology, Vol 38(4), May 2024, 322-336; doi:10.1037/neu0000943Objective: The present study explored psycholinguistic analysis of spoken responses produced in a structured interview and cued linguistic and nonlinguistic task switching as possible novel markers...